Markets:

Overview

News

Currencies

International

Treasuries

Jazz Pharmaceuticals plc - Ordinary Shares (NQ:JAZZ)

186.39 -1.88 (-1.00%)

Streaming Delayed Price Updated: 11:56 AM EDT, Apr 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Jazz Pharmaceuticals plc - Ordinary Shares

< Previous 1 2

...

10 11 12 13 14 15 16 17 Next >

Agentix Corp. (AGTX) Signs Deal With NHRI To License CBD-Based Compound To Treat Type 2 Diabetes; Adds Catalyst To Back Half Of 2021

June 02, 2021

Via AB Newswire

Topics Intellectual Property

The Daily Biotech Pulse: Pfizer In Vaccine Supply Talks With India, Provention In Focus Ahead Of Briefing Doc, NeuroRx To List Via SPAC Deal ↗

May 25, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 24) Bristol-Myers Squibb Company...

Via Benzinga

Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge ↗

May 01, 2021

Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name...

Via Benzinga

This Could Be The Most Exciting Healthcare Development Of The Year

May 21, 2021

Via FinancialNewsMedia

Topics Artificial Intelligence Cannabis

Medical Stocks Jazz, Horizon Are Accelerating But Iqvia Is Hitting The Brakes ↗

May 17, 2021

Jazz Pharmaceuticals and Horizon Therapeutics are among a cadre of accelerating medical stocks, while big names like Iqvia Holdings are hitting the brakes.

Via Investor's Business Daily

10 Biggest Price Target Changes For Monday ↗

May 17, 2021

Morgan Stanley boosted the price target on Applied Materials, Inc. (NASDAQ: AMAT) from $113 to $137. Applied Materials shares fell 1.1% to $123.46 in pre-market trading....

Via Benzinga

Cramer Advises Viewers On Suncor, Jazz And More ↗

May 14, 2021

On CNBC's "Mad Money Lightning Round," Jim Cramer said that in the energy space he is recommending only Chevron Corporation (NYSE: CVX) and Pioneer Natural Resources...

Via Benzinga

The Daily Biotech Pulse: Merck Reports Positive Keytruda Data In Breast Cancer, Curis, Evoke Slump On Earnings, Qiagen's Rapid COVID-19 Antibody Test OK'ed For Emergency Use ↗

May 13, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 12) Alexion Pharmaceuticals, Inc...

Via Benzinga

The Week In Cannabis: The New Tilray, Jazz-GW Pharma, Earnings, M&A, And More ↗

May 07, 2021

This was an eventful week for the cannabis industry. On Monday, Tilray, Inc. (NASDAQ:

Via Benzinga

Topics Cannabis

Jazz Pharmaceuticals Closes On Acquisition Of GW Pharma, Adds CBD Drug Epidiolex To Portfolio ↗

May 06, 2021

The biopharmaceutical company Jazz Pharmaceuticals, has finalized the acquisition of the cannabinoid drug company GW Pharmaceuticals plc.

Via Talk Markets

Jazz Pharmaceuticals Closes On Acquisition Of GW Pharma, Adds CBD Drug Epidiolex To Portfolio ↗

May 06, 2021

The biopharmaceutical company Jazz Pharmaceuticals (NASDAQ: JAZZ), has finalized the acquisition of the cannabinoid drug company GW Pharmaceuticals plc. (NASDAQ: GWPH). The...

Via Benzinga

Jazz Pharmaceuticals' Acquisition of GW Pharmaceuticals Closes ↗

May 05, 2021

The developer of cannabis-based medications is now under new ownership.

Via The Motley Fool

Jazz Pharmaceuticals PLC (JAZZ) Q1 2021 Earnings Call Transcript ↗

May 04, 2021

JAZZ earnings call for the period ending March 31, 2021.

Via The Motley Fool

Topics Earnings

Jazz Pharma Easily Beats Earnings Views, But Sales Come In Light ↗

May 04, 2021

Late Tuesday, Jazz Pharma reported adjusted earnings of $3.92 per share on $607.58 million in sales for its first quarter. Jazz stock was unmoved.

Via Investor's Business Daily

The Daily Biotech Pulse: Vaxart Rebounds On Strong Vaccine Data, Pfizer's Beat-And-Raise Quarter, BioLineRx Data ↗

May 04, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 3) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

GW Pharmaceuticals Stockholders Approve Acquisition by Jazz Pharmaceuticals ↗

April 23, 2021

Jazz is about to get the top cannabis-derived drug on the market, in addition to a robust pipeline.

Via The Motley Fool

Topics Cannabis

Alzheimer's Disease: 5 Stocks on Biotech Radars ↗

April 22, 2021

What's been interesting for the past couple of years, and especially the last few months, is to watch the rise of emerging, small-cap Biotech companies trying to take on the big AD and other...

Via Talk Markets

PAO Group, Inc. Rallies 21% On Monday; Investor Update This Morning Adds Fuel To Bullish Sentiment

April 13, 2021

Via AB Newswire

Topics Cannabis Intellectual Property

Healthcare Investors: Here's What You Need to Know About Medical Marijuana ↗

April 11, 2021

Although research on the medical benefits of the drug is limited in the U.S., we have some ideas about marijuana's ability to disrupt the healthcare industry.

Via The Motley Fool

Topics Cannabis

< Previous 1 2

...

10 11 12 13 14 15 16 17 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.